<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Ramos, L.</title>
    <link>http://repub.eur.nl/res/aut/3776/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Sperm-derived histones contribute to zygotic chromatin in humans (Article)</title>
      <link>http://repub.eur.nl/res/pub/30335/</link>
      <pubDate>2008-05-15T00:00:00Z</pubDate>
      <description>Background. about 15% to 30% of the DNA in human sperm is packed in nucleosomes and transmission of this fraction to the embryo potentially serves as a mechanism to facilitate paternal epigenetic programs during embryonic development. However, hitherto it has not been established whether these nucleosomes are removed like the protamines or indeed contribute to paternal zygotic chromatin, thereby potentially contributing to the epigenome of the embryo. Results. to clarify the fate of sperm-derived nucleosomes we have used the deposition characteristics of histone H3 variants from which follows that H3 replication variants present in zygotic paternal chromatin prior to S-phase originate from sperm. We have performed heterologous ICSI by injecting human sperm into mouse oocytes. Probing these zygotes with an antibody highly specific for the H3.1/H3.2 replication variants showed a clear signal in the decondensed human sperm chromatin prior to S-phase. In addition, staining of human multipronuclear zygotes also showed the H3.1/H3.2 replication variants in paternal chromatin prior to DNA replication. Conclusion. these findings reveal that sperm-derived nucleosomal chromatin contributes to paternal zygotic chromatin, potentially serving as a template for replication, when epigenetic information can be copied. Hence, the execution of epigenetic programs originating from transmitted paternal chromatin during subsequent embryonic development is a logical consequence of this observation. </description>
    </item> <item>
      <title>Surgical sperm retrieval and intracytoplasmic sperm injection as treatment of obstructive azoospermia (Article)</title>
      <link>http://repub.eur.nl/res/pub/8815/</link>
      <pubDate>1998-01-01T00:00:00Z</pubDate>
      <description>Male genital tract obstructions may result from infections, previous
          inguinal and scrotal surgery (vasectomy) and congenital bilateral absence
          of the vas deferens (CBAVD). Microsurgery can sometimes be successful in
          treating the obstruction. In other cases and in cases of failed surgical
          intervention, the patient can be treated by microsurgical or percutaneous
          epididymal sperm aspiration (MESA, PESA) or testicular sperm extraction
          (TESE) and intracytoplasmic sperm injection (ICSI). We present the results
          of 39 ICSI procedures for obstructive azoospermia in 24 couples. The
          aetiology of the obstruction was failed microsurgery in 11 patients, CBAVD
          in nine and genital infections in four. Sperm retrieval was accomplished
          via MESA in four cases, PESA in 18 cases and via TESE in 11 cases. TESE
          was only applied when PESA failed to produce enough spermatozoa for
          simultaneous ICSI. In six patients, the ICSI procedure was performed with
          cryopreserved spermatozoa after an initial PESA procedure. Fertilization
          occurred in 47% of the metaphase II oocytes; embryo transfer was performed
          in 92% of procedures and resulted in a clinical pregnancy in 13/39
          procedures. Ongoing pregnancy was achieved in 10/39 procedures. One
          pregnancy was terminated early after prenatal investigation showed a
          cytogenetic abnormality (47,XX+18, Edwards syndrome). The other nine
          pregnancies resulted in the live birth of 10 children, without any
          congenital abnormalities. Epididymal and testicular retrieved spermatozoa
          were successfully used for ICSI to treat obstructive azoospermia, and
          resulted in an ongoing pregnancy in 10 of 24 couples (41.6%) after 39 ICSI
          procedures, a success rate of 25.6% per treatment cycle and of 27.7% per
          embryo transfer.</description>
    </item>
  </channel>
</rss>